Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 802625, 8 pages
http://dx.doi.org/10.1155/2012/802625
Research Article

Bioassay-Guided Isolation of Neuroprotective Compounds from Uncaria rhynchophylla against Beta-Amyloid-Induced Neurotoxicity

1School of Chinese Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong
2Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago IL 60607, USA

Received 27 March 2012; Accepted 12 May 2012

Academic Editor: Karl Wah-Keung Tsim

Copyright © 2012 Yan-Fang Xian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. D. Dayan, “Quantitative histological studies on the aged human brain—II. Senile plaques and neurofibrillary tangles in senile dementia (with an appendix on their occurrence in cases of carcinoma),” Acta Neuropathologica, vol. 16, no. 2, pp. 95–102, 1970. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Hardy and D. J. Selkoe, “The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics,” Science, vol. 297, no. 5580, pp. 353–356, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. W. H. Zheng, S. Bastianetto, F. Mennicken, W. Ma, and S. Kar, “Amyloid β peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures,” Neuroscience, vol. 115, no. 1, pp. 201–211, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Peng, C. Xing, S. Xu et al., “L-3-n-butylphthalide improves cognitive impairment induced by intracerebroventricular infusion of amyloid-β peptide in rats,” European Journal of Pharmacology, vol. 621, no. 1–3, pp. 38–45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. C. L. Hsieh, M. F. Chen, T. C. Li et al., “Anticonvulsant effect of Uncaria rhynchophylla (Miq) Jack, in rats with kainic acid-induced epileptic seizure,” American Journal of Chinese Medicine, vol. 27, no. 2, pp. 257–264, 1999. View at Google Scholar · View at Scopus
  6. C. L. Hsieh, N. Y. Tang, S. Y. Chiang, C. T. Hsieh, and L. Jaung-Geng, “Anticonvulsive and free radical scavenging actions of two herbs, Uncaria rhynchophylla (Miq) Jack and Gastrodia elata Bl., in kainic acid-treated rats,” Life Sciences, vol. 65, no. 20, pp. 2071–2082, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Endo, Y. Oshima, and H. Kikuchi, “Hypotensive principles of Uncaria hooks,” Planta Medica, vol. 49, no. 3, pp. 188–190, 1983. View at Google Scholar · View at Scopus
  8. H. Fujiwara, K. Iwasaki, K. Furukawa et al., “Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer's β-amyloid proteins,” Journal of Neuroscience Research, vol. 84, no. 2, pp. 427–433, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Q. Lin, M. T. Ho, L. S. Lau, K. K. Wong, P. C. Shaw, and D. C. C. Wan, “Anti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer's disease,” Chemico-Biological Interactions, vol. 175, no. 1–3, pp. 352–354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. F. Xian, Z. X. Lin, M. Zhao, Q. Q. Mao, S. P. Ip, and C. T. Che, “Uncaria rhynchophylla ameliorates cognitive deficits induced by D-galactose in mice,” Planta Medica, vol. 77, no. 18, pp. 1977–1983, 2011. View at Google Scholar
  11. Y. F. Xian, Z. X. Lin, Q. Q. Mao, S. P. Ip, Z. R. Su, and X. P. Lai, “Protective effect of isorhynchophylline against β-amyloid-induced neurotoxicity in PC12 cells,” Cellular and Molecular Neurobiology, vol. 32, no. 3, pp. 353–360, 2012. View at Publisher · View at Google Scholar
  12. J. Zhang, C. J. Yang, and D. G. Wu, “Studies on the chemical constituents of Uncaria rhynchophylla (Miq) Jack. (II),” Zhong Cao Yao, vol. 29, no. 10, pp. 649–651, 1998. View at Google Scholar
  13. T. Nozoye, Y. Shibanuma, and A. Shigehisa, “Uncaria alkaloids. XXI. Separation of rhynchophylline and corynoxeine (Japanese),” Yakugaku Zasshi, vol. 95, no. 6, pp. 758–759, 1975. View at Google Scholar · View at Scopus
  14. J. Haginiwa, S. Sakai, and N. Aimi, “Studies of plants containing indole alkaloids. (II). The alkaloids of Uncaria rhynchophylla Miq,” Yakugaku Zasshi, vol. 93, no. 4, pp. 448–452, 1973. View at Google Scholar · View at Scopus
  15. P. J. Houghton and E. J. Shellard, “The Mitragyna species of Asia. XXVIII. The alkaloidal pattern in Mitragyna rotundifolia from Burma,” Planta Medica, vol. 26, no. 2, pp. 104–112, 1974. View at Google Scholar · View at Scopus
  16. T. Nozoye, “Studies on uncaria alkaloid. XX. Structure of rhynchophylline. 5. Structure of rhynchophylline and isorhynchophylline,” Chemical & Pharmaceutical Bulletin, vol. 6, no. 3, pp. 309–312, 1958. View at Google Scholar · View at Scopus
  17. C. P. Hoi, Y. P. Ho, L. Baum, and A. H. L. Chow, “Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells,” Phytotherapy Research, vol. 24, no. 10, pp. 1538–1542, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Berts and K. P. Minneman, “Tyrosine kinase inhibitors and Ca2+ signaling: direct interactions with fura-2,” European Journal of Pharmacology, vol. 389, no. 1, pp. 35–40, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. J. S. Shim, H. G. Kim, M. S. Ju, J. G. Choi, S. Y. Jeong, and M. S. Oh, “Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease,” Journal of Ethnopharmacology, vol. 126, no. 2, pp. 361–365, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Liu, Z. Q. Zhang, X. M. Zhao, and Y. S. Gao, “Protective effect of Uncaria rhynchophylla total alkaloids pretreatment on hippocampal neurons after acute hypoxia,” Zhongguo Zhongyao Zazhi, vol. 31, no. 9, pp. 763–765, 2006. View at Google Scholar · View at Scopus
  21. K. Suk, S. Y. Kim, K. Leem et al., “Neuroprotection by methanol extract of Uncaria rhynchophylla against global cerebral ischemia in rats,” Life Sciences, vol. 70, no. 21, pp. 2467–2480, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Kawakami, H. Kanno, Y. Ikarashi, and Y. Kase, “Yokukansan, a kampo medicine, protects against glutamate cytotoxicity due to oxidative stress in PC12 cells,” Journal of Ethnopharmacology, vol. 134, no. 1, pp. 74–81, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Yuan, B. Ma, J. Y. Yang et al., “Anti-inflammatory effects of rhynchophylline and isorhynchophylline in mouse N9 microglial cells and the molecular mechanism,” International Immunopharmacology, vol. 9, no. 13-14, pp. 1549–1554, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. H. J. Lu, J. Q. Tan, S. S. Durairajan et al., “Isorhynchophylline, a natural alkaloid, promotes the degradation of alpha-synuclein in neuronal cells via inducing autophagy,” Autophagy, vol. 8, no. 1, pp. 98–108, 2012. View at Google Scholar
  25. B. L. Kelly and A. Ferreira, “β-amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons,” Journal of Biological Chemistry, vol. 281, no. 38, pp. 28079–28089, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. J. T. T. Zhu, R. C. Y. Choi, H. Q. Xie et al., “Hibifolin, a flavonol glycoside, prevents β-amyloid-induced neurotoxicity in cultured cortical neurons,” Neuroscience Letters, vol. 461, no. 2, pp. 172–176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Sul, H. S. Kim, D. Lee, S. S. Joo, K. W. Hwang, and S. Y. Park, “Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation,” Life Sciences, vol. 84, no. 9-10, pp. 257–262, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Berridge, P. Lipp, and M. D. Bootman, “The calcium entry pas de deux,” Science, vol. 287, no. 5458, pp. 1604–1605, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Rapoport, H. N. Dawson, L. I. Binder, M. P. Vitek, and A. Ferreira, “Tau is essential to β-amyloid-induced neurotoxicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 9, pp. 6364–6369, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. F. M. LaFerla and S. Oddo, “Alzheimer's disease: Aβ, tau and synaptic dysfunction,” Trends in Molecular Medicine, vol. 11, no. 4, pp. 170–176, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. M. G. Spillantini and M. Goedert, “Tau protein pathology in neurodegenerative diseases,” Trends in Neurosciences, vol. 21, no. 10, pp. 428–433, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Leschik, A. Welzel, C. Weissmann, A. Eckert, and R. Brandt, “Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-β in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-β-induced cell death,” Journal of Neurochemistry, vol. 101, no. 5, pp. 1303–1315, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. X. W. Zhou, X. Li, C. Bjorkdahl et al., “Assessments of the accumulation severities of amyloid β-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains,” Neurobiology of Disease, vol. 22, no. 3, pp. 657–668, 2006. View at Publisher · View at Google Scholar · View at Scopus